MedTrace Logo

Drug Use Investigation for LAMICTAL

NCT01376180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2016-11-09

No results posted yet for this study

Summary

The purpose of this study is to grasp actual status of usage of lamotrigine tablet and to collect information for using lamotrigine tablet effectively and safely as well as to grasp onset status of adverse events in pediatric subjects, geriatric subjects, pregnant women, subjects with poor renal and hepatic functions.

Conditions

Interventions

DRUG

Lamotrigine

Administered according to the prescribing information in the locally approved label by the authorities

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2016-08-31
Completion
2016-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01376180 on ClinicalTrials.gov